EW
46
3
INTC
40
-4
RL
80
2
HSIC
60
-2
PPL
59
5
GILD
54
3
HUM
41
-2
CVS
52
-6
AVY
54
-4
RF
67
-2
ABBV
50
8
SJM
45
9
GRMN
67
-3
BXP
60
5
SPG
63
7
EXPE
93
2
KSS
26
-15
AMT
45
2
EXPD
48
-5
MRK
35
2
EW
46
3
INTC
40
-4
RL
80
2
HSIC
60
-2
PPL
59
5
GILD
54
3
HUM
41
-2
CVS
52
-6
AVY
54
-4
RF
67
-2
ABBV
50
8
SJM
45
9
GRMN
67
-3
BXP
60
5
SPG
63
7
EXPE
93
2
KSS
26
-15
AMT
45
2
EXPD
48
-5
MRK
35
2
Financhill
Back

Himax Technologies Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
45

HIMX
Himax Technologies

Last Price:
5.13
Seasonality Move:
31.81%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.77
Seasonality Move:
14.88%
Sell
45
Himax Technologies (HIMX) is a Sell

Is Himax Technologies a Buy, Sell or Hold?

  • The current Himax Technologies [HIMX] share price is $5.23. The Score for HIMX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • HIMX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HIMX Stock Price Chart

What is Himax Technologies's stock price today?

  • The Himax Technologies share price today is $5.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HIMX is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

HIMX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 36.74 Sell
Chaikin Money Flow: -590536 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.29 - 6.01) Sell
Bollinger Bands (100): (5.24 - 6.86) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

HIMX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.24 Sell
20-day SMA: 5.52 Sell
50-day SMA: 5.71 Sell
200-day SMA: 6.02 Sell
8-day EMA: 5.3 Sell
20-day EMA: 5.49 Sell
50-day EMA: 5.7 Sell
200-day EMA: 6.03 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Himax Technologies Earnings Growth & HIMX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.20 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Himax Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):